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Abstract
Introduction: It	has	already	been	reported	in	many	types	of	malignant	tumors	that	
a	solid	metastasis	can	have	a	different	histology	and	more	aggressive	state	than	
the	primary	tumor.	
Case presentation: We	 report	 the	 case	 of	 a	 60-year-old	 smoker	 woman	 who	
presented	with	bone	metastasis	that	histologically	proved	to	be	an	adenocarcinoma.	
Bronchoscopy	revealed	a	squamous	cell	 lung	cancer	that	–	despite	the	different	
histology	–	was	regarded	as	the	primary	tumor.	Two	weeks	later	a	rapidly	growing	
skin	tumor	developed	that	was	also	a	squamous	cell	carcinoma,	and	was	regarded	
as	the	distant	metastasis	of	the	endobronchial	cancer.	
Conclusions: In	lung	cancer	it	is	important	not	to	exclude	the	possibility	of	tumor	
dissemination	 even	 if	 the	 suspected	 primary	 tumor	 and	 the	 distant	metastasis	
have	different	histologies.	
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Background
It	is	well	known	that	a	metastasis	can	have	a	different	histology	
and	more	aggressive	state	than	the	primary	tumor	[1,2].
Case presentation
A	 60-year-old	 heavy	 smoker	 female	 (pack-year	 index:	 38)	 was	
admitted	to	the	Department	of	Pulmonology	of	the	Semmelweis	
University	 in	 June	 2013,	 after	 surgery	 because	 of	 pathologic	
fracture	 due	 to	 right	 pelvic	 lytic	 metastasis.	 Histologically,	
the	 pelvic	 tumor	 mass	 proved	 to	 be	 a	 poorly	 differentiated	
adenocarcinoma	 with	 codon	 12	 point	 mutation	 of	 the	 KRAS	
gene	 (glycine	 (GGT)	 to	 valine	 (GTT)	 conversion)	 characteristic	
for	 smoking-related	 genetic	 changes.	 The	 method	 used	 for	
KRAS	 mutation	 analysis	 has	 already	 been	 described	 in	 our	
previous	work	by	Cserepes	et	al.	[3].	Bronchoscopy	revealed	an	
endobronchially	 visible	 tumor	 in	 the	 right	 lower	 lobe	bronchus	
that	was	diagnosed	histologically	as	a	TTF-1	(thyroid	transcription	
factor-1)	 negative	 and	 p63	 positive	 squamous	 cell	 carcinoma,	
and	 was	 regarded	 as	 the	 primary	 tumor.	 Thoracic	 CT	 showed	
paratracheal	lymph	node	enlargement	and	a	small,	lobular	right	
upper	 lobe	nodule	both	regarded	as	metastases.	Abdominal	CT	
scan	 showed	 enlarged	 left	 adrenal	 gland	 referring	 to	 adrenal	
metastasis.	 Two	 weeks	 after	 her	 admission,	 rapidly	 growing	
multiple	cystic	subcutaneous	nodules	with	inflammatory	changes	
developed	on	 the	 chest	wall	 in	 the	 left	 axillary	 line.	 Aspiration	
cytology	showed	squamous	cell	carcinoma	that	was	regarded	as	
the	distant	metastasis	of	the	right	central	lung	cancer.	During	her	
hospitalization	pathologic	fracture	of	the	left	humerus	occurred.	
The	 general	 condition	 of	 the	 patient	 deteriorated	 rapidly	 and	
she	died	5	weeks	after	her	admission	even	without	having	 the	
opportunity	 to	 receive	 palliative	 oncotherapy.	 In	 summary,	 in	
this	 patient	 both	 the	 primary	 tumor	 and	 the	 subcutaneous	
metastases	were	squamous	cell	carcinomas;	however,	the	pelvic	
bone	 metastasis	 proved	 to	 be	 an	 anaplastic	 adenocarcinoma.	
Neither	thoracic	CT	nor	bronchoscopy	showed	any	other	 lesion	
that	 could	 have	 been	 regarded	 as	 synchronous	 primary	 lung	
cancer	or	other	primary	tumor,	such	as	thyroid	or	breast	cancer.	
Moreover,	abdominal	CT	did	not	show	other	 lesion	referring	to	
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extrathoracic	primary	tumor	but	only	adrenal	metastasis,	typical	
metastatic	site	of	lung	cancer.		
Discussion
In	 the	 presented	 case	 we	 might	 speculate	 that	 the	 right	 lower	
lobe	 endobronchial	 tumor	 contained	 adenosquamous	 elements,	
and	during	the	metastatic	process	a	tumor	cell	selection	occurred	
resulting	 in	different	histology	 from	 the	primary	 lung	 cancer.	 This	
is	 in	accordance	with	the	concept	of	tumor	cell	heterogeneity,	 i.e.	
highly	metastatic	cells	are	present	as	a	sub-population	in	a	primary	
tumor.	It	is	well	known	that	there	are	different	mechanisms	of	clonal	
variation	 including	 clonal	 selection,	 parallel	 evolution,	 dynamic	
heterogeneity,	 clonal	 dominance	 and	 stem	 cell	 expansion	 [4].	 In	
lung	adenocarcinoma,	the	prognostic	significance	of	KRAS	mutation	
has	 already	 been	 documented	 [5].	 The	 correlation	 between	
primary	 tumor	and	bone	metastasis	 in	non-small	 cell	 lung	 cancer	
was	 investigated	 by	 Badalian	 et	 al,	who	 demonstrated	 that	 KRAS	
mutational	status	of	the	primary	tumor	did	not	predict	the	status	of	
the	bone	metastatic	tissue,	since	they	had	observed	both	emergence	
of	mutant	 clones	 in	metastases	 from	wild-type	 primary	 tumors	
and	loss	of	mutant	clones	in	metastases	from	mutant	primaries	
in	addition	to	the	maintained	mutant	status	[6].	
Skin	 metastases	 from	 lung	 cancer	 are	 rare	 with	 a	 reported	
incidence	of	1-2%	[7].	They	are	more	frequent	 in	patients	aged	
over	40	years,	and	are	associated	with	a	particularly	aggressive	
biological	behavior	[8].	In	our	patient	active	oncotherapy,	which	
could	 have	 contributed	 to	 an	 artificial	 selection	 pressure	 for	
clonal	 divergence	 or	 stem	 cell	 expansion	 was	 not	 possible	 to	
imply,	therefore,	this	case	might	prove	that	even	in	the	absence	of	
therapeutic	intervention	histological	difference	between	primary	
tumor	and	metastasis	can	be	observed.							
Conclusion
In	our	case,	multiple	distant	metastases	with	different	histology	
could	 be	 demonstrated.	 The	 skin	 involvement	 had	 the	 same	
squamous	 cell	 carcinoma	histology	as	 the	primary	 lung	 cancer,	
while	the	bone	metastasis	was	found	to	be	an	adenocarcinoma	
with	a	molecular	 feature	 that	might	be	 regarded	as	one	of	 the	
most	aggressive	ones	in	the	adenocarcinoma	subgroup.	
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